Nevro Corp (NYSE:NVRO)
$ 5.06 -0.26 (-4.89%) Market Cap: 188.65 Mil Enterprise Value: 166.94 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 42/100

Nevro Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 10:00PM GMT
Release Date Price: $58.34 (+0.52%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

The next presentation. Again, I'm Bob Hopkins from BofA. Absolutely thrilled to have Nevro here today. And on behalf of Nevro, the company's new CEO, Keith Grossman, is here. Keith, thank you very much for being here. It's one of the sessions I've been most looking forward to since we organized this conference. Also, thank you to Juliet Cunningham who does the Investor Relations; and Andrew, the company's Chief Financial Officer, is here as well. So we'll do entire fireside chat here, if okay, Keith?

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Okay.

Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

I mean, your -- if you have anything kind of you want to lead with, please, or I'll just to jump into the questions.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Why don't you just jump in, yes?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot